Accelerated global burden of depressive disorders during the COVID-19 pandemic from 2019 to 2021
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
A thorough and current analysis of the burden and evolving trends in depressive disorders during the COVID-19 pandemic from 2019 to 2021 remains unavailable. Employing the Global Burden of Disease (GBD) 2021 database, we evaluated the burden of depressive disorders at the global, regional, and national levels, stratifying the analysis by age, gender, and socio-demographic index (SDI). To examine trends in depressive disorders during the epidemic, we calculated the estimated annual percentage change (EAPC) in age-standardized incidence rates (ASIR), age-standardized prevalence rates (ASPR), and age-standardized DALYs rates (ASDR) across all levels from 2019 to 2021. Furthermore, we performed a frontier analysis of depressive disorders across various countries, incorporating risk factor analyses at multiple levels. In 2021, the global incidence of depressive disorders stood at 357.43 million, while the prevalence was recorded at 332.41 million, accompanied by 56.33 million disability-adjusted life years (DALYs). Throughout the COVID-19 pandemic, there was a notable upward trend in ASIR (EAPC = 8.33 [-0.46 to 17.9]), ASPR (EAPC = 6.02 [0.28 to 12.09]), and ASDR (EAPC = 7.13 [-0.18 to 14.97]) for depressive disorders on a global scale. The burden of depressive disorders is most pronounced among females and individuals aged 60 to 64 within their respective subgroups. From 1990 to 2021, the burden of depressive disorders consistently remained highest in the low SDI region; however, it experienced the most significant increase in the high SDI region during the COVID-19 pandemic from 2019 to 2021. In 2021, the burden of depressive disorders was highest in central sub-Saharan Africa, Greenland, and Uganda, while the Andean region of Latin America, along with Bulgaria and Belarus, experienced the most significant increase in depressive disorders during the COVID-19 pandemic. Globally, bullying victimization, intimate partner violence, and childhood sexual abuse contributed to 6.47%, 4.91%, and 2.65% of the ASDR for depressive disorders, respectively. The global burden of depressive disorders has markedly increased during the COVID-19 pandemic, gradually shifting from low to high SDI regions, particularly in North America and Europe.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Murray, C. J. L., Aravkin, A. Y., Zheng, P., Abbafati, C., Abbas, K. M., Abbasi-Kangevari, M., Abd-Allah, F., Abdelalim, A., Abdollahi, M., Abdollahpour, I., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30752-2 · Cited by 9,854 · cited 1×
“Additionally, the GBD 2021 study employed the Bayesian meta-regression tool, DisMod-MR 2.1, as the principal methodology, ensuring consistency in the incidence, prevalence, and DALYs across all diseases 11,12 .”
InfluentialSelf-citationSantomauro, D. F., Mantilla Herrera, A. M., Shadid, J., Zheng, P., Ashbaugh, C., Pigott, D. M., Abbafati, C., Adolph, C., Amlag, J. O., Aravkin, A. Y., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)02143-7 · Cited by 5,444
Ferrari, A. J., Santomauro, D. F., Aali, A., Abate, Y. H., Abbafati, C., Abbastabar, H., Abd ElHafeez, S., Abdelmasseh, M., Abd-Elsalam, S., Abdollahi, A., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00757-8 · Cited by 5,112
Self-citationMalhi, G. S., & Mann, J. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31948-2 · Cited by 4,099
Age of onset of mental disorders: a review of recent literature
Kessler, R. C., Amminger, G. P., Aguilar-Gaxiola, S., Alonso, J., Lee, S., & ??st??n, T. B. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32816ebc8c · Cited by 3,457
The Epidemiology of Depression Across Cultures
Kessler, R. C., & Bromet, E. J. (2013) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031912-114409 · Cited by 2,657
Why is depression more common among women than among men?
Kuehner, C. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30263-2 · Cited by 1,752
Depression and cardiovascular disease: a clinical review
Hare, D. L., Toukhsati, S. R., Johansson, P., & Jaarsma, T. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht462 · Cited by 1,362
Estrogen Actions in the Central Nervous System1
McEwen, B. S., & Alves, S. E. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0365 · Cited by 1,358 · cited 1×
“In female physiology, estrogen plays a crucial role in mood regulation by modulating neurotransmitter turnover and enhancing serotonergic activity 21 .”
Avenevoli, S., Swendsen, J., He, J.-P., Burstein, M., & Merikangas, K. R. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2014.10.010 · Cited by 1,202
Research works printed but not linked: 1
- McEwen, B. S. & Alves, S. E. Estrogen actions in the central nervous system [J]. Endocr. Rev. 20(3), 279–307 (1999).
Cited by
Zhang, Z., Chen, X., Wu, S., Chen, X., Wang, X., Liu, C., Zeng, N., Liu, Y., Huo, T., Liu, X., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120299 · Cited by 119
Bochenska, N., Tomczak, J., & Lisek, M. (2025) · Antioxidants · doi:10.3390/antiox14121464 · Cited by 19
“The impact of depressive disorders is greatest among females and people aged 60 to 64 within their respective demographic groups [1].”
InfluentialLisowska, K. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262010092 · Cited by 15
“Major depressive disorder (MDD) is a highly prevalent and disabling psychiatric condition, affecting more than 300 million people globally [1].”
Advances in the prevalence and treatment of depression for adolescents: a review
Yin, C., Xu, M., & Zong, Z. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1574574 · Cited by 15
Hanifa, H., Alzoubi, M., Khallouf, E. S., Alzoubi, L., Hamesh, F., Qashqash, M. E., Albaroudi, F. H., Al-Baroudy, M., Mahouk, M. A. M., Al-Mashaqbah, Y. M., et al. (2025) · BMC Psychology · doi:10.1186/s40359-025-03879-3 · Cited by 5
“In 2014, over 300 million people worldwide suffered from depression [6].”
Metadata
- Authors
- Zhou, J., Zhang, Y., He, S., Xu, S., Sun, Q., Zhao, T., & Dai, Y.
- Affiliations
- Zhejiang Provincial People's Hospital (CN)
- Zhejiang Chinese Medical University (CN)
- Corresponding author
- Zhao, Tingxiao
- Dai, Yaqin
- Venue
- Scientific Reports
- Published
- 2025-03-19
- Volume
- 15
- Issue
- 1
- Pages
- 9529-9529
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC11923300
- OpenAlex
- W4408611311
- Cited by
- 20
- References
- 38
- Citations by year
- 2026: 12 · 2025: 8
- FWCI
- 23.63
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- depressive disorders, COVID-19 pandemic, global burden of disease, disability-adjusted life years, incidence and prevalence trends, socio-demographic index, sex differences, age differences, bullying victimization, intimate partner violence, child sexual abuse, risk factors, mental health burden, sub-Saharan Africa, Latin America, Eastern Europe, Pacific Islands, Middle East and North Africa, South Asia, North America
- MeSH terms
- Global Burden of Disease, COVID-19, SARS-CoV-2, Disability-Adjusted Life Years, Adolescent, Adult, Aged, Depressive Disorder, Female, Humans, Male, Middle Aged, Risk Factors, Global Health, Incidence, Prevalence, Cost of Illness, Young Adult, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Accelerated global burden of depressive disorders during the COVID-19 pandemic from 2019 to 2021. https://app.cochat.ai/papers/10.1038/s41598-025-93923-4
- The paper
- Zhou, J., Zhang, Y., He, S., Xu, S., Sun, Q., Zhao, T., & Dai, Y. (2025). Accelerated global burden of depressive disorders during the COVID-19 pandemic from 2019 to 2021. Scientific Reports. https://doi.org/10.1038/s41598-025-93923-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.